Novartis AG
SIX:NOVN
Novartis AG
Revenue
Novartis AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novartis AG
SIX:NOVN
|
Revenue
$46.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Revenue
CHf58.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Revenue
$9.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novartis AG's Revenue?
Revenue
46.7B
USD
Based on the financial report for Dec 31, 2023, Novartis AG's Revenue amounts to 46.7B USD.
What is Novartis AG's Revenue growth rate?
Revenue CAGR 10Y
-1%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Novartis AG have been -2% over the past three years , and -1% over the past ten years .